Central Obesity and Disease Risk in Japanese Americans

Clinical Trial ID NCT00005365

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00005365

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 1999 2.25
2 Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men. Diabetes Care 1995 1.44
3 Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 1999 1.26
4 Susceptibility to development of central adiposity among populations. Obes Res 1995 1.15
5 Diabetes and diabetes risk factors in second- and third-generation Japanese Americans in Seattle, Washington. Diabetes Res Clin Pract 1994 1.07
6 Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Int J Obes Relat Metab Disord 2000 1.00
7 Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans. Diabetes Care 1995 0.94
8 Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men. Diabetes 1996 0.90
9 Increased plasma leptin levels are associated with fat accumulation in Japanese Americans. Diabetes 1998 0.89
10 Visceral adiposity, fasting plasma insulin, and lipid and lipoprotein levels in Japanese Americans. Int J Obes Relat Metab Disord 1996 0.88
11 Effect of regional fat distribution and Prader-Willi syndrome on plasma leptin levels. J Clin Endocrinol Metab 1997 0.83
12 Hypertension in Japanese Americans: the Seattle Japanese-American Community Diabetes Study. Public Health Rep 1996 0.78
13 Fasting insulin level underestimates risk of non-insulin-dependent diabetes mellitus due to confounding by insulin secretion. Am J Epidemiol 1997 0.77
Next 100